Microbiota and COVID -19: Microbial Dysbiosis

SARS-CoV-2 causes an acute respiratory syndrome named COVID-19.This virus spread across the globe rapidly and started a pandemic.Many researchers are pursuing finding the mechanisms involved in the disease course and methods of controlling them.In addition to respiratory symptoms, COVID-19 demonstrates digestive symptoms; These findings suggest that microbiota might play a role in the development of COVID-19.Studies showed that lung and gut microbiota composition could change by SARS-CoV-2, and microbial dysbiosis affects disease development and severity.Based on these findings, manipulation of the microbiota utilizing diet, antibiotics, prebiotics, or probiotics can be beneficial in COVID-19 management and improving vaccine efficiency.